IL143576A0 - Pharmaceutical preparation for inhalation of an opioid - Google Patents

Pharmaceutical preparation for inhalation of an opioid

Info

Publication number
IL143576A0
IL143576A0 IL14357698A IL14357698A IL143576A0 IL 143576 A0 IL143576 A0 IL 143576A0 IL 14357698 A IL14357698 A IL 14357698A IL 14357698 A IL14357698 A IL 14357698A IL 143576 A0 IL143576 A0 IL 143576A0
Authority
IL
Israel
Prior art keywords
inhalation
opioids
dry powder
administered
opioid
Prior art date
Application number
IL14357698A
Other languages
English (en)
Original Assignee
Pharmachemie Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmachemie Bv filed Critical Pharmachemie Bv
Publication of IL143576A0 publication Critical patent/IL143576A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14357698A 1998-12-11 1998-12-11 Pharmaceutical preparation for inhalation of an opioid IL143576A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL1998/000713 WO2000035417A1 (en) 1998-12-11 1998-12-11 Pharmaceutical preparation for inhalation of an opioid

Publications (1)

Publication Number Publication Date
IL143576A0 true IL143576A0 (en) 2002-04-21

Family

ID=19866466

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14357698A IL143576A0 (en) 1998-12-11 1998-12-11 Pharmaceutical preparation for inhalation of an opioid
IL143576A IL143576A (en) 1998-12-11 2001-06-05 Pharmaceutical preparation for inhalation of an opioid

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL143576A IL143576A (en) 1998-12-11 2001-06-05 Pharmaceutical preparation for inhalation of an opioid

Country Status (11)

Country Link
US (1) US20010041164A1 (de)
EP (1) EP1137398B1 (de)
JP (1) JP2002532405A (de)
AT (1) ATE251447T1 (de)
AU (1) AU1786199A (de)
CA (1) CA2354576C (de)
DE (1) DE69818872T2 (de)
DK (1) DK1137398T3 (de)
ES (1) ES2207867T3 (de)
IL (2) IL143576A0 (de)
WO (1) WO2000035417A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
CA2446904A1 (en) 2001-05-24 2003-04-03 Alexza Pharmaceuticals, Inc. Delivery of drug esters through an inhalation route
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
DE60231611D1 (de) * 2001-05-24 2009-04-30 Alexza Pharmaceuticals Inc Verabreichung von opioiden durch inhalation
US8273331B2 (en) * 2002-08-21 2012-09-25 Norton Healthcare Ltd. Inhalation compositions
GB0219513D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Inhalation compositions including coarse carrier
BRPI0408059A (pt) * 2003-02-28 2006-02-14 Delex Therapeutics Inc sistema de administração de opióides
CA2526478A1 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Methods of controlling uniformity of substrate temperature and self-contained heating unit and drug-supply unit employing same
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
AU2004322756B2 (en) 2004-08-12 2011-04-14 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heat packages
WO2006124556A2 (en) * 2005-05-13 2006-11-23 Glaxo Group Limited Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
ES2594867T3 (es) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Unidad de calentamiento para usar en un dispositivo de administración de fármaco
AU2010206724A1 (en) * 2009-01-22 2011-07-28 Nanotherapeutics, Inc. Process for preparing particles of opioids and compositions produced thereby
MX2020007997A (es) 2018-02-02 2020-12-03 Alexza Pharmaceuticals Inc Dispositivo electrico de aerosol de condensacion.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
GB9103302D0 (en) * 1991-02-16 1991-04-03 Smithkline Beecham Plc Pharmaceutical formulations
US6017963A (en) * 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
GB9606188D0 (en) * 1996-03-23 1996-05-29 Danbiosyst Uk Pollysaccharide microspheres for the pulmonary delivery of drugs
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation

Also Published As

Publication number Publication date
ES2207867T3 (es) 2004-06-01
US20010041164A1 (en) 2001-11-15
EP1137398A1 (de) 2001-10-04
CA2354576A1 (en) 2000-06-22
EP1137398B1 (de) 2003-10-08
AU1786199A (en) 2000-07-03
ATE251447T1 (de) 2003-10-15
DE69818872D1 (de) 2003-11-13
DE69818872T2 (de) 2004-05-19
DK1137398T3 (da) 2004-02-02
IL143576A (en) 2006-10-31
WO2000035417A1 (en) 2000-06-22
JP2002532405A (ja) 2002-10-02
CA2354576C (en) 2008-10-14

Similar Documents

Publication Publication Date Title
AU1786199A (en) Pharmaceutical preparation for inhalation of an opioid
CA2146954A1 (en) Breath activated nicotine inhalers
PL312205A1 (en) Inhalable therapeutic preparation
US20190046436A1 (en) Nicotine formulation and aerosols
PL340994A1 (en) Method of administering therapeutic substances by inhalation and inhaler therefor
ATE281828T1 (de) Nikotininhalator
YU36302A (sh) Novi tiotropiumski preparati - koji sadrže prah za inhaliranje
LV12586A (en) Aerosolized active agent delivery
HUP0101293A3 (en) Aspb28-human insulin comprising pharmaceutical composition administered by inhalation and their use
CA2304819A1 (en) Perforated microparticles and methods of use
MY115688A (en) Pharmaceutical composition for administration by inhalation
EA200100338A1 (ru) Способ и устройство для введения действующего вещества в виде аэрозоли в легкие пациента
WO2000023065A8 (de) Lagerfähiges wirkstoffkonzentrat mit formoterol
WO2002024158A8 (en) Pulmonary delivery in treating disorders of the central nervous system
MY124329A (en) Active substance concentrate with formoterol, suitable for storage.
US11006661B2 (en) Cigarette-like device for administration of substances
JP2001527442A (ja) ハロセラピーの投与方法
TW200607538A (en) Medicament inhaler device
FI962665A0 (fi) Menetelmä ja sovitelma intuboidun potilaan hengityMenetelmä ja sovitelma intuboidun potilaan hengityskaasun käsittelemiseksi skaasun käsittelemiseksi
GB9806462D0 (en) Improved compositions for inhalation
IL177764A0 (en) Opioid delivery system
EP1110547A3 (de) Helium und Neon als Hilfsstoffe zur Wirkstoffverabreichung mittels Inhalator
WO2002055057A3 (en) Treatment of asthma and other lung conditions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees